Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-07-096244
Filing Date
2007-04-30
Accepted
2007-04-30 17:16:17
Documents
3
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K d10ka.htm 10-K/A 296602
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 9003
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 8976
  Complete submission text file 0001193125-07-096244.txt   316378
Mailing Address 1501 EAST WOODFIELD ROAD SUITE 300 EAST SCHAUMBURG IL 60173-5837
Business Address 1501 EAST WOODFIELD ROAD SUITE 300 EAST SCHAUMBURG IL 60173-5837 847-969-2700
Abraxis BioScience, Inc. (Filer) CIK: 0001141399 (see all company filings)

EIN.: 680389419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-33407 | Film No.: 07801793
SIC: 2834 Pharmaceutical Preparations